Search

Your search keyword '"Beige J."' showing total 267 results

Search Constraints

Start Over You searched for: Author "Beige J." Remove constraint Author: "Beige J."
267 results on '"Beige J."'

Search Results

1. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

2. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

4. Baroreflexaktivierungstherapie bei therapieresistenter Hypertonie: Empfehlungen der BAT-Konsensusgruppe zu Implantation und Nachsorge

5. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease

6. Barorezeptorakivierungstherapie bei therapierefraktärer Hypertonie: Indikation und Patientenselektion: Empfehlungen der BAT-Konsensusgruppe 2017

14. Data sharing under the general data protection regulation: Time to harmonize law and research ethics?

16. Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

19. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

23. Baroreflexaktivierungstherapie bei therapieresistenter Hypertonie

26. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

28. Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

30. Characteristics of high- and low-risk individuals in the PRIORITY study:urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

32. Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017

35. Reconstructive kidney surgery for organ-preserving therapy of renal tumors

36. No evidence of systemic CMV reactivation in chronic hemodialysis patients: a single centre experience

37. Beta-lactam continuous infusion therapy (BLACIT) compared to linezolid or vancomycin in the treatment of catheter-related Staphylococcus aureus blood-stream infections (CRBSI-SA) in hemodialysis patients – a retrospective analysis

39. Serum levels of the adipokine adipocyte fatty acid binding protein are increased in chronic and acute renal dysfunction

40. Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy

41. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

48. Le matériel et les exigences associées

Catalog

Books, media, physical & digital resources